Ensuring the Quality of our Products

On May 7, 2018, Impax Laboratories, Inc. combined with Amneal Pharmaceuticals, Inc. (NYSE:AMRX) to create a dynamic company powered by a robust U.S. generics business and growing branded franchise. Today, we are working to integrate our business into the new Amneal and are excited about our future as one company.

Impax is committed to continuous quality improvement resulting in the development, production, and delivery of high-quality products for our patients and customers. We comply with all applicable laws and regulations regarding our research, development, manufacturing and distribution activities, including current Good Clinical Practices (“cGCP”), Good Manufacturing Practices (“cGMP”), and Good Laboratory Practices (“cGLP”) (collectively, “Good Operating Practices” or “cGxP”), among other practices.

We take quality-related complaints seriously, and ensure that any complaints are properly investigated and reported, as required, to the appropriate regulatory authorities.

To Report a Product Complaint please contact:

Phone: (877) 99-Impax (46729), option 2
Phone: (510) 240-6450, option 2
Email: inquiries@impaxlabs.com
Impax Laboratories
31047 Genstar Road
Hayward, CA 94544
Attention: Regulatory Compliance Customer Complaints

Follow link below for Impax Adverse Event and Product Complaint Report Form: http://ae.impaxlabs.com

Ethics and Compliance Information

U.S. Ethics Hotline: (877) 412-8817